Unusual Machines reports today with a quarter of its float still short, a stock up 58% in a month, and analysts lining up on the buy side — the setup is as charged as it gets for a small-cap drone name.
The short position has barely moved since the last article two days ago. Short interest remains at 25.1% of free float, with the modest day-on-day and week-on-week dips suggesting shorts are not rushing for cover despite the stock's 12% gain this week alone. Borrow availability is tight at roughly 24% — about one share available for every four already lent out — but the cost to borrow at 1.1% is too low to force a squeeze. The 52-week low of 7.3% availability is a useful reference point: shorts could absorb considerably more pressure before the borrow market becomes genuinely painful. Options positioning has nudged more defensive into the print, with the put/call ratio at 0.53, running above its 20-day average of 0.46 by nearly 1.7 standard deviations — elevated, but well within the past year's range of 0.25 to 0.76.
The analyst community is unusually aligned for a stock this contentious. Piper Sandler initiated with an Overweight rating and a $38 target just two days ago. Needham raised its target from $30 to $40 following the last earnings print in early August. HC Wainwright and Roth Capital both carry Buy ratings with targets in the $40–$42 range. The consensus price target of $37.75 implies roughly 38% upside from Wednesday's close of $27.24, a gap that reflects genuine disagreement between the Street and the short sellers rather than a valuation technicality. Bulls point to government endorsement of domestic drone hardware and a strengthening balance sheet. Bears focus on the risk of delayed program awards and the reality that the company is still loss-making, with earnings power deeply negative.
Institutional ownership adds an interesting wrinkle. BlackRock reported adding more than 2.2 million shares as recently as July 31, bringing its stake to 7.3% of shares outstanding. State Street also added roughly 633,000 shares in the same period. That institutional accumulation at the top of the register sits alongside a cluster of insider selling from June, when the President unloaded $3 million in shares and the CFO sold $2.7 million — trades that occurred when the stock was priced in the mid-to-high $20s, close to where it trades today. The insider selling warrants attention, though it predates the most recent leg of analyst upgrades.
The print will test whether the revenue trajectory and any commentary on government program timelines can justify a stock that has doubled year-to-date, against a short base that has been adding — not covering — through the entire rally.
See the live data behind this article on ORTEX.
Open UMAC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
